skip to primary navigationskip to content

Cambridge Institute for Medical Research

Department A-Z

Our strategy

We aim to create an inspiring environment in which outstanding scientists can excel. By providing state-of-the-art core facilities and support for our researchers, we foster new collaborations that spark discoveries about fundamental cellular processes and their relevance in disease.

Read more

Research advances

In eLife, the Nathan lab uncover a new pathway linking the V-ATPase proton pump with iron metabolism to regulate stabilization of the hypoxia-inducible transcription factor HIF1a.

Read more

Research advances

In PLoS Genetics, the Maxwell lab report the first example of a disease-causing mutation in the mitochondrial DNA promoter region, and highlight the sensitivity of the kidney to such mutations.

Read more


Apply to be the next Director of the CIMR and Professor of Cell Biology.

Read more

New Wellcome Trust Henry Dale Fellow

Congratulations to Delphine Larrieu, who has been awarded a Dale Fellowship to start her research group this year.

Read more

Incredible Medicine

Geoff Woods discusses his research on those rare individuals who are born unable to feel pain in the BBC2 series on Incredible Medicine.

Read more

A unique partnership between basic and clinical research, aiming to understand the cellular basis of disease

New publications


Reid lab (J. Cell Biol. 2017)

ER-endosome contacts and lysosome function in HSPs


Ron lab (BMC Biol. 2017)

Tracking ER hydrogen peroxide.


Rubinsztein lab (Brain 2017)

Autophagy upregulation as strategy for tauopathies.


Read lab (PNAS 2017)

Predicting crystal structure success.


Maxwell lab (PLoS Genet. 2017)

Altered mitochondrial RNA translation in kidney disease.


Rubinsztein lab (Neuron 2017)

Autophagy in neuronal health and disease.


Buss lab (PNAS 2017)

Cytoskeletal control by myosin VI motor directionality.